Stephens Inc’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,046
Closed -$44.1K 1295
2023
Q2
$44.1K Sell
1,046
-45
-4% -$1.82K ﹤0.01% 1179
2023
Q1
$38.9K Buy
1,091
+12
+1% +$435 ﹤0.01% 1147
2022
Q4
$39.6K Sell
1,079
-158
-13% -$6.25K ﹤0.01% 1121
2022
Q3
$58K Hold
1,237
﹤0.01% 1125
2022
Q2
$89K Hold
1,237
﹤0.01% 1131
2022
Q1
$100K Sell
1,237
-5
-0.4% -$423 ﹤0.01% 1223
2021
Q4
$128K Hold
1,242
﹤0.01% 1246
2021
Q3
$109K Buy
+1,242
New +$112K ﹤0.01% 1265

Other funds holding SYNH

Stephens Inc's SYNH Position: Q3 2023 in Review

Stephens Inc sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 1,046 shares — an estimated $44.1K sold.

Stephens Inc first reported a position in SYNH in Q3 2021 and held it in 8 quarters. The position peaked at $128K in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Stephens Inc reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Stephens Inc sold 1,046 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $44.1K.
  • Stephens Inc first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2021 and held it in 8 quarters.
  • Stephens Inc's Syneos Health, Inc. Class A Common Stock position peaked at $128K in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Stephens Inc's 13F filing for Q3 2023, filed 14 Nov 2023.